2023-510047-37-00
EU Clinical Trials Information System
- Trial ID
- T-ctis-2023-510047-37-00
- Registry
- EU Clinical Trials Information System
- CTIS number
- 2023-510047-37-00
- Asset
- GH001
- Sponsor, as registered
- GH Research Ireland Limited
- Phase
- Therapeutic exploratory (Phase II)
- Indication
- Treatment-resistant depression (TRD)
- Status
- Ended
- Start date
- 30/03/2023
- Primary completion
- CTIS does not publish one.
- Member states concerned
- Czechia, Germany, Ireland, Poland, Spain
- Sites
- 10
Member states whose regulator has a decision on this trial.
euclinicaltrials.euctis registryverified 2026-08-31
Notes on the record
countries is memberStatesConcerned, i.e. every member state the trial is filed in; site_count sums trialSites across authorised Part II sections. primary_completion_date is EMPTY because CTIS does not publish a primary completion date; it is not unknown, it is not a field the registry has. Per-state authorisation is NOT recorded: mscPublicStatusCode takes values [8] on this record and the registry publishes no key for them, so decoding it would be a guess.
Company
Through GH001: GH Research
Cited in
No published issue cites this registry number.